C 3 H mice were found to be much less responsive to tumor induction in an initiation/promotion protocolthan CD-1 mice. To explore the difference in strain sensitivity, the frequencies of cells resistant to calcium-induced terminal differentiation(calcium resistantcells, CRCs) were measured in C 3 H, CD-1, and SENCAR mice. The induced frequencies after 7,12-dimethylbenz(a)anthracene (DMBA) treatment were similar in all three strains, ranging from 0.70 to 0.83 £ 10 ¡ 6 , and suggested that the differences in tumor outcome were more likely related to promotion than initiation. Spontaneous frequencies ranged from 0.73 to 3.75 CRCs per mouse or 0.07 to 0.22 CRC/10 6 cells. The spontaneous frequency in the C 3 H mouse was signi® cantly less than that in the other two strains. However, the spontaneous mutation rates were found to be similar in all three strains, ranging from 0.05 to 0.07 £ 10 ¡ 6 and it was found that the keratinocytes, which were resistant to terminal differentiation, were independently distributed in C 3 H but not in CD-1 and SENCAR mice. These data are consistent with the hypothesis that clonal expansion occurs in CD-1 and SENCAR but not C 3 H mice. Conceivably the greater propensity for clonal expansion in CD-1 and SENCAR than in C 3 H mice is related to the greater likelihood of tumor formation as well as the more rapid development of tumors in the former strains.
; however, that strain has been reported to be less responsive in initiation/ promotion studies than other mouse strains including CD-1 and SENCAR (DiGiovanni et al. 1992; Elmets et al. 1992; Kinoshita and Gelboin 1972; Stenback 1980) . Consistent with reports from other laboratories (Di Giovanni et al. 1984) , we report here that the C 3 H mouse is much less responsive than the CD-1 in initiation/promotion bioassays.
To investigate whether the difference in sensitivity was related to initiating or promoting processes, the spontaneous and induced frequencies of skin cells resistant to calcium-induced terminal differentiation (Yuspa and Morgan 1981) were measured. It is believed that these calcium resistant cells (CRCs) represent an early stage in the carcinogenic process (Kawamura, Strickland, and Yuspa 1985; Kulesz-Martin et al. 1983; Miller et al. 1987 Miller et al. , 1989 . Although there is evidence that CRCs can arise spontaneously (Kawamura, Strickland, and Yuspa 1985; Przygoda et al. 1994; Yuspa and Morgan 1981) , the frequency is substantiallyincreased by treatment with genotoxicskin carcinogens such as dimethylbenz(a)anthracene (DMBA) (Przygoda et al. 1994; Yuspa and Morgan 1981) , suggesting that the induction of resistance to terminal differentiation is the result of a mutational process. Presumably increases in CRC frequency following mutagen treatment are re¯ective of the skin tumor initiation process. Consequently, frequencies were measured in three strains, C 3 H, CD-1, and SENCAR, a strain speci® cally bred for sensitivity in the initiation/promotion protocol. The speci® c objective was to determine whether these three mouse strains were equally sensitive to tumor initiation as measured in this way. A unique feature of the study design is the preparation of keratinocytes cultures from individual animals as opposed to pooling of keratinocytes insolated from the entire treatment group. This allows the data to be analyzed by statistical methods which was not done with pooled data (Yuspa and Morgan 1981; Kawarmura, Strickland, and Yuspa 1985) .
MATERIALS AND METHODS

Animal Husbandry
Male C 3 H and CD-1 mice, approximately 6±7 weeks of age for the initiation/promotion studies and 4±5 weeks of age for the CRC studies, were obtained from Charles River, Kingston, NY. Male SENCAR mice (4±5 weeks of age) were obtained from Harlen Sprague Dawley, Inc., Indianapolis, IN. After a 2-week quarantine period, mice of each strain were randomly distributed by weight into test groups of appropriate size. The mice were singlyhoused in suspended wire mesh cages and given ad libitum access to Zeigler Pellets (Zeigler, Gardners, PA.) and water. All other matters of animal husbandry were in accordance with the recommendations of the Guide for Care and Use of Laboratory Animals (U.S. Department of Health, Education, and Welfare 1985) .
Initiation/Promotion Assays
To compare the sensitivity of the C 3 H and CD-1 strains in the initiation/promotion protocol, four test groups of 30 mice each were examined. Mice were initiated only, promoted only, both initiated and promoted, and treated with vehicle in both segments of the study (i.e., the negative control) as shown in Table 1 . During the ª initiationº phase of the study (the ® rst 2 weeks), mice were treated with 10 l g DMBA (39 nmol; Sigma, St Louis, MO) dissolved in acetone and given as single 25-l l dermal applications. Mice which were not initiated were not treated during this period. During the ª promotionº phase, animals were treated three times weekly with 2.5 l g phorbol 12-myristate 13-acetate (PMA) (4 nmol) dissolved in 25 l l acetone. Mice which were not promoted were treated with 25 l l acetone only.
Most of the mice were sacri® ced after 193 days (approximately 27 weeks); however, two groups of CD-1 mice (acetonetreated and promoted only) were also used as controls for another experiment and were ultimately treated for about a year. Data shown for groups tested longer than 193 days were from gross observations made at the time the other mice were sacri-® ced, unless otherwise designated. Final results from these two groups are shown in Table 3 of McKee, Plutnick, and Przygoda (1989) .
Skin tumors were counted and grossly diagnosed on a weekly basis. Following study termination, ® nal gross tumor counts were made, and the mice were sacri® ced. A skin tumor was diagnosed as a papilloma if it displayed one or more of the following characteristics: (1) projected from the surface of the skin;
(2) attached to the skin by a small stalk; (3) appeared roughened and wartlike; and (4) was freely moveable and not attached to underlying tissue. A skin tumor was classi® ed as a squamous cell carcinoma if it displayed one or more of the following characteristics: (1) had a broad-based attachment to the skin; (2) was ulcerated and/or hemorrhagic;(3) attached to and invaded deeper tissues, and therefore, might not be freely movable from subcutaneous tissue, and; (4) skin immediately adjacent to the growth was thickenedand ® rm. Sections of skin from the treatment areas were removed and examined microscopically to con® rm tumor count and diagnosis.Visceral organs were examined microscopically only if abnormalities were noted during necropsy. Because no treatment-related ® ndings were noted other than the epidermal ® ndings, the results of the visceral examination have not been provided. Tumor frequencies were compared by Fisher' s Exact Test (Bradley 1968 ).
Assessment of Frequency of Cells Resistant to Calcium-Induced Terminal Differentiation
For this study C 3 H, CD-1, and SENCAR mice were randomly distributed into groups of 10±15. The entire dorsal surfaces of the mice were shaved 2 days prior to dosing, and treatment was by topical application of 0.2 ml of either 100 nanomoles DMBA (97%, Aldrich Chemical Company, Milwaukee, WI) in acetone (99.7%, J.T. Baker Inc., Phillipsburg, NJ) or acetone only. All mice were between the ages of 6 to 8 weeks when the majority of the mice are in the resting phase of the hair growth cycle (Berenblum, Haran-Ghera, and Trainin 1958; Borum 1954) .
Basal keratinocytes were isolated using a modi® cation of the methods of Morris et al. (1987) . Two weeks after dosing, mice were sacri® ced and residual hair was removed. After washing with detergent followed by 70% ethanol, a skin section (approximately 20 cm 2 from C 3 H and 24 cm 2 from CD-1 and SENCAR, the difference being due to the size difference between the strains) was removed from each treated mouse and immersed in phosphate-buffered saline (GIBCO, Grand Island, NY). Each skin section was placed dermal side up in a sterile Petri dish, and the subcutaneous tissue was scraped with a scalpel until the skin was translucent. The skin was then cut into approximately 1 £ 1.5 cm 2 pieces and¯oated dermal side down, on the surface of a 0.75£ trypsin solution(10£ trypsin,GIBCO, Grand Island, NY, diluted in a phosphate-bufferedsaline without calcium or magnesium).
After incubation for 1 hour at 32 ± C and 45±60 minutes at room temperature, the epidermis was scraped from the dermis into Minimal Eagles Medium (MEM, Whittaker Bioproducts, Inc. Waldesville,MD.) containing10% fetal bovine serum (FBS, HyClone Laboratories, Logan, UT). Epidermal fragments were minced with scissors, and the suspensions were magnetically stirred for 20 minutes. The cells were ® ltered through nylon mesh, centrifuged for 10 minutes at 1000 rpm and then resuspended in calcium-free MEM, supplemented with 10% FBS. Viable cells from individual mice (determined by trypan blue exclusion) were resuspended in Low (0.05 mM) calcium keratinocyte growth medium (LoKGM; Clonetics Corp., San Diego, CA.) and seeded at a cell density of 3 £ 10 6 cells/ml into 25 cm 2 asks precoated with a ® bronectin/collagenmixture (Kawamura, Strickland, and Yuspa 1985) .
A modi® cation of the method of Yuspa and Morgan (1981) was used to identify CRCs, i.e., cells which were resistant to calcium-induced terminal differentiation. Keratinocytes were incubated for 2 days in LoKGM at 32 ± C, and then refed with high (0.6 mM) calcium keratinocyte growth medium (HiKGM). For the next 4 to 5 weeks, cultures were incubated at 37 ± C and were refed twice weekly using HiKGM. At the end of this time period, cells were ® xed with 10% formalin and stained with rhodamine B. Foci of CRC (i.e., red-staining colonies greater than 5 mm in diameter) were counted and subsequently veri® ed by microscopic examination.
The means and standard deviations of the viable cell counts, the percent viable cells, the number of CRC per animal, and the number of CRC per million cells for each test group were calculated. Species and treatment differences were assessed by a standard analysis of variance (ANOVA) test (Snedecor and Cochran 1971) . Residuals from the ANOVA were analyzed for normality by Wilk's criterion (Shapiro and Wilk 1965) . The residuals from viable cell counts and the percent viable cells were found to be normally distributed and, therefore, ANOVA was used to compare group means. The number of CRC per animal and the number per million cells were found not to be normally distributed. Accordingly, these parameters were evaluated with Poisson statistics.
Several investigators have demonstrated that mutation frequency data has an extra-Poisson distribution both in vitro (Green et al. 1990; Leroux and Krewski 1993; Luria and Delbruck 1943) and in vivo (Heddle et al. 1992) . Assuming the CRCs to be mutational events, the CRC data were analyzed by Poisson statistics using the methods of Breslow and Day (1987) and also were found to have an extra-Poisson distribution. Therefore, these data were analyzed using an iterative process to accommodate the extra-Poisson variation (Breslow 1984; Breslow 1990) .
Data from all mice were analyzed unless (1) the total number of viable cells harvested was less than 9 million per animal;
(2) less than 40% of the cells were viable; or (3) fewer than 75% of the cultures survived at the time of staining (Przygoda et al. 1994) .
RESULTS
Initiation/Promotion Study
The majority of the animals survived to scheduled sacri® ce, and none of the early deaths appeared treatment-related. Other than dermal effects, there were no apparent clinical ® ndings, and no consistent abnormalities were noted at necropsy. Weight gain was not affected. The C 3 H mice weighed approximately 25 g at study initiation and 32 g at termination. The CD-1 mice weighed approximately 29 g at study initiation and approximately 42 g at termination. There were no signi® cant differences in weight between groups of mice of the same strain, although the CD-1 mice were signi® cantly larger than the C 3 H over the entire study period.
During the in-life phase of this study, 25 of 30 of the CD-1 mice which were initiated and promoted developed grossly observable tumors ( Table 2 ). The microscopic examination revealed that all 30 mice were tumor bearing. Within this group there was an average of approximately 2 tumors per mouse and, although most of the tumors were papillomas, one had become malignant.
None of the C 3 H mice had grossly observabletumors, but four tumors, all papillomas, were noted during the microscopic examination. No other mice developed tumors during this phase of the study. Some of the uninitiated CD-1 mice which were PMA treated also developed tumors, but the ® rst of these appeared after day 193. When sacri® ced after 352 days of treatment, four PMA-treated CD-1 mice had grossly observable tumors and nine had histologically veri® ed tumors. Skin sections from C 3 H and CD-1 mice which had not been treated with PMA were unremarkable. However, most of the PMA-treated mice exhibited subepidermal in¯ammatory in® ltrate. Most of the PMA-treated C 3 H mice also had necrotic cell debris present on the epidermal surface, and many exhibited diffuse acanthosis and epidermal necrosis. Among PMA-treated CD-1 mice, most had diffuse acanthosis, and the presence of necrotic cell debris was also a common ® nding. Erosion and ulceration were relatively common among the uninitiated PMAtreated mice but not among the initiated and promoted mice. However, most mice in the latter group had tumors, and this may have made the determinationof other effects dif® cult. Thus, there were some differences in skin reactions to PMA treatment between strains, but these appeared to be relatively minor. No attempt was made to assess these differences quantitatively.
Assessment of Frequency of Cells Resistant to Calcium-Induced Terminal Differentiation
There were more than three times as many spontaneous CRC per CD-1 mouse (2.67) as there were in C 3 H mice (0.73) (Table 3) . However, a substantial portion of this difference was apparently related to the number of viable cells recovered as the difference was only about a factor of two when expressed as frequency per million viable cells (0.07 vs. 0.16). The reason for the better recovery in the CD-1 strain is not known, although 20% more skin was recovered from the CD-1 than from the C 3 H mice due to the size difference between strains. SENCAR mice treated similarly had 3.75 CRC/mouse or approximately 0.22/million viable cells, and cell recovery in this strain was similar to that in CD-1. The spontaneous frequencies in the SENCAR and CD-1 strains were both signi® cantly greater than that in C 3 H, but were not signi® cantly different from each other. The frequency of CRCs 14 days after treatment with 100 nanomoles DMBA was increased by approximately a factor of 10 in C 3 H, a factor of 5 in CD-1, and a factor of 6 in SEN-CAR mice. The increases were signi® cantly different from the respective controls in all strains. On a per animal basis, there were approximately twice as many DMBA-induced CRCs in the CD-1 and SENCAR strains as in C 3 H; however, when expressed on a per million basis and corrected for background, the frequencies were almost identical: 0.70 in C 3 H, 0.75 in CD-1, and 0.83 in SENCAR.
DISCUSSION
In the initiation/promotion assay, it was evident that the CD-1 strain was much more responsive than the C 3 H. Within 6 months, all CD-1 mice initiated with DMBA and promoted with PMA developedtumors, in most cases multipletumors, and in one case a malignancy. In contrast, none of the initiated and promoted C 3 H mice developed grossly observable tumors, and only four were found to have microscopically identi® ed papillomas.
In other studies (DiGiovanni et al. 1992; Elmets et al. 1992) , it has been shown that tumors can be produced in the C 3 H strain if the mice are treated with substantially higher levels of DMBA and PMA than are used in corresponding studies with SENCAR mice. Thus, it is clear that C 3 H mice are responsive in initiation/promotion assays but substantially less so than the CD-1 (present study) or the SENCAR (DiGiovanni et al. 1992 ) mice. However, as higher levels of both DMBA and PMA were required to produce equivalent effects in the C 3 H mouse, it is dif® cult to know whether the difference in response was related to initiation, promotion, or a combination of the two.
To explore the basis for the difference in strain sensitivity, the spontaneous and DMBA-induced frequencies of CRCs were measured in C 3 H, CD-1, and SENCAR mice. The spontaneous CRC frequencies in the CD-1 and SENCAR strains were signi®cantly greater than that in C 3 H. However, the DMBA-induced CRC frequencies were essentially the same in all three strains when expressed on a per million viable cell basis and within approximately a factor of two when expressed on a per animal basis. Thus differences between the three strains after treatment with DMBA were relatively minor and, to the extent that the increases in CRC frequency re¯ect initiation,all strains responded in a similar manner. Thus, the differences in sensitivity in the initiation/promotion study seem more likely to have been related to promotion than to initiation. Other investigators (Kawamura, Strickland, and Yuspa 1985; Nesnow, Bergman, and Slaga 1986; Reiners, Nesnow, and Slaga 1984) , using somewhat different types of experiments, have reached similar conclusions.
One possible explanation for the greater spontaneous CRC frequency in CD-1 and SENCAR mice is that clonal expansion is more likely in these strains than in C 3 H. To test this hypothesis, the distributions of the CRC data were analyzed using the Poisson statistical methods as modi® ed by Breslow (Breslow 1984 (Breslow , 1990 and Luria and Delbruck (1943) . The Poisson statistical model itself, a method well suited to the evaluation of the number of rare events in a very large number of trials, is particularly useful for mutational response data. If the induction of CRCs occurs independently, then they would be expected to be randomly distributed. However, if clonal expansion occurs, some of the CRCs will be derived from preexisting cells, and the distribution will no longer be random. Mathematically, in strains in which little or no clonal expansion occurs, the CRC data would be expected to be described by a Poisson distribution with a variance equal to the mean (Luria and Delbruck 1943) , but if clonal expansion occurs, then one would expect a variance greater than the mean (Heddle et al. 1992; Luria and Delbruck 1943) .
The distribution of CRCs among the C 3 H mice approximated a Poisson distribution with a mean CRC frequency of 0.73/mouse and a variance of 0.49. The analysis suggests that in this strain, the CRCs arose by independent events and that little or no clonal expansion occurred. Among the SENCAR mice, the variance (25.1) was approximatelysix times the mean (3.75). Among the CD-1 mice, the variance (6.86) was approximately twice the mean (2.67). These departures from the Poisson distribution characteristic of equal mean and variance suggest that in these strains the CRCs did not all arise independently. The simplest interpretation is that clonal expansion occurred in the SENCAR and CD-1 strains. It should also be noted that the difference between the SENCAR and CD-1 strains was due to an exceptionally high response in one SENCAR mouse (Table 4 ). If this animal is censored from the analysis, the means and variances in the SENCAR and CD-1 strains are almost identical, although still different from C 3 H.
Statistical methods based on the Poisson distribution can also be used to estimate the mutation rate, as opposed to the observed mutation frequency (Lura and Delbruck 1943) . Assuming CRC induction to be a mutational process, the average number of in which ª p 0 º is the proportion of animals with no CRCs and ª mº is the average number of mutations per animal. The mutation rate ª aº can be calculated by using the equation
In which ª N t º is the average number of cells harvested per animal and ª N 0 º is the number of cells at a time period earlier in the animal's development.For convenience,ª N 0 º was assumed to be very small relative to ª N t º . The proportions of animals with no CRCs were 0.40, 0.33, and 0.375 in C 3 H, CD-1, and SENCAR, respectively. Both the average number of CRCs per animal, ª m,º 0.92 (C 3 H), 1.1 (CD-1), and 0.98 (SENCAR), and the estimated mutation rates ª a,º 0.070 £ 10 ¡ 6 (C 3 H), 0.063 £ 10 ¡ 6 (CD-1), and 0.054 £ 10 ¡ 6 (SENCAR), were approximately the same in all strains. This result (i.e., that the mutation rates are equivalent but the mutant frequencies are different) is also consistent with the hypothesis that clonal expansion occurs in CD-1 and SENCAR but not C 3 H mice.
Spontaneous mutations in mouse keratinocytes can be generated by suboptimal culture conditions (Greenhalgh et al. 1989 ). The media used by these researchers was different than that used in the studies reported in this article. If spontaneous CRCs were generated from culture conditions, then the distribution of CRCs would be expected to approximate a Poisson distribution (Luria and Delbruck 1943) . In CD-1 and SENCAR mice, substantialdeviations from the Poisson distribution were observed. Although in the C 3 H mouse deviations from the Poisson distribution were not observed, the estimated mutation rate for the C 3 H was the same as for the CD-1 and SENCAR mice. This suggests that the source of the spontaneous CRCs is the same for all three strains. Therefore, the origin of the spontaneous CRCs appears to be from the animals and not due to in vitro culture conditions. Kawamura, Strickland, and Yuspa (1985) drew attention to the presence of CRCs in untreated cultures of keratinocytes derived from SENCAR mice. They suggested that this was evidence for a population of constitutively initiated cells which could develop into tumors following treatment with promoting agents such as PMA. To determine if that hypothesis was plausible, the data from individual mice of all three strains in the present study were analyzed separately (Table 4) , permitting a comparison of the number of CRCs/mouse to the number of tumors which developed in uninitiated mice after treatment with promoting agents. We previously reported that in the C 3 H mouse, there were approximately 0.28 CRCs within the area which would be treated in a dermal carcinogenesis study. This was approximately twice the frequency (0.13 tumors/mouse) at which tumors arose in that strain after repeated treatment with agents which are not mutagenic and apparently act strictly by promotional processes (Przygoda et al. 1994) . It should be noted that, for purposes of this and the analysis given in the following paragraph, we have assumed complete recovery of the CRCs. In fact, we have no convenient method of assessing recovery, so the number found actually represents the minimum number present at any time.
Using similar calculations, in the CD-1 mouse there were approximately 2.67 CRCs/mouse which presumably represented 1.1 independent events (based on an observed mutant frequency to mutation rate ratio of 0.16 £ 10 ¡ 6 to 0.063 £ 10 ¡ 6 ). To determine the number of cells or foci which might be expected in an area of the same size used in a dermal carcinogenesis study, it was necessary to multiply the number of independent events by 0.21 (the ratio of treatment areas used in the dermal carcinogenesis study, 5 cm 2 , to that used in the keratinocyte assay, 24 cm 2 ), yielding approximately 0.23 events/dermal carcinogenesis region. In the SENCAR mouse, a similar calculation also yielded 0.23 events/dermal carcinogenesis region. In our laboratory, CD-1 mice which were treated for approximately a year with PMA produced 9/30 and 4/30 tumors in separate studies (McKee, Plutnick, and Przygoda 1989) , or approximately 0.22 tumors/mouse. Among SENCAR mice treated with promoters for 50 weeks, there were 9 tumors in 40 animals (Pelling, Neades, and Strawhecker 1988), a frequency of 0.23 tumors/mouse. Assuming the frequencies in the two strains to be equivalent, approximately 94% (i.e., 0.22 tumors/mouse of 0.23 events/mouse = 0.94) of the independentevents became tumors after repeated promotion, or approximatelytwice the frequency at which this happened in the C 3 H mouse. Conceivably, the greater propensity for clonal expansion in CD-1 and SEN-CAR mice than in C 3 H is related to the greater likelihood of tumor formation as well as the more rapid development of tumors in the former two strains.
In summary, it was found that CD-1 mice were much more responsive in initiation/promotion assays than are C 3 H. However, the frequency of induced CRCs following DMBA treatment was similar between these two strains and also to that in SENCAR mice. Thus the difference in sensitivity between strains seems more likely related to promotion than to initiation. It was also noted that the spontaneous CRC frequencies differed signi®cantly among strains, the frequencies in CD-1 and SENCAR being higher than in C 3 H, although the rate of formation is similar in all three strains. These results suggest a greater likelihood of clonal expansion in CD-1 and SENCAR than in C 3 H mice.
